Study of sebaloxavir marboxil to prevent flu in household contacts
Part of Infections clinical trials.
This study tests a new medication, sebaloxavir marboxil, to see if it can prevent the flu in people who live with someone who has the flu. If you qualify, you would take the study drug and be monitored for a few weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old.
- You have been living with someone who has the flu for at least 48 hours.
- You can stay in the same home as that person for at least 7 days after starting the study.
- You test negative for the flu at the start of the study.
- You have not had a flu vaccine in the last 6 months.
- You have not taken any flu medications in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two flu medicines, oseltamivir and baloxavir marboxil, to see if they can prevent flu in people who are in the hospital and were exposed to someone with the flu. It may help you avoid getting sick while you are in the hospital.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This trial tests whether a single dose of an antiviral medicine (baloxavir marboxil) can prevent the flu in people who live with someone who has the flu. It's designed for household contacts who are not yet sick but have been exposed.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This study tests an investigational flu medicine (called Suraxavir Marboxil) for children with the flu. The goal is to see if it safely and effectively treats flu symptoms and shortens the illness.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
Hear when a new Influenza Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.